{"created":"2023-05-15T08:20:14.480101+00:00","id":157,"links":{},"metadata":{"_buckets":{"deposit":"639e4162-9122-472e-bdfb-b9c61ea188e6"},"_deposit":{"created_by":3,"id":"157","owners":[3],"pid":{"revision_id":0,"type":"depid","value":"157"},"status":"published"},"_oai":{"id":"oai:shobi-u.repo.nii.ac.jp:00000157","sets":["10:2:32"]},"author_link":["253"],"control_number":"157","item_3_biblio_info_12":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2014-10-31","bibliographicIssueDateType":"Issued"},"bibliographicPageEnd":"9","bibliographicPageStart":"1","bibliographicVolumeNumber":"25","bibliographic_titles":[{"bibliographic_title":"尚美学園大学総合政策研究紀要","bibliographic_titleLang":"ja"},{"bibliographic_title":"Bulletin of policy and management, Shobi University","bibliographic_titleLang":"en"}]}]},"item_3_description_10":{"attribute_name":"抄録(日)","attribute_value_mlt":[{"subitem_description":"現行安倍政権は2025年までを視野に入れた長期戦略である『イノベーション25』を上奏し、「イノベーション創造と生産性の向上」を成長戦略の中枢として医薬品・医療機器の開発を促進すべきであると主張した。この視点に基づき、医療先進国と謳われるイギリスの医療政策と同国の基幹産業とされる医薬品産業の動向を検証した。現行のキャメロン政権下では経済危機前のピーク水準を上回る成長が達成されているが、これを支えた個人消費の伸びは、実質所得の伸び悩みと生産性の改善不足から、鈍化に転じ今後の経済成長の伸び悩みが現れるものと予想され、現状でも厳しい緊縮財政が図られている。また、我が国と同様に人口の高齢化に対応した医療費削減策がサッチャー政権下より継続的に展開され、様々な医療制度改革が実施されている。この様な環境の中で、近年大手製薬業界の大規模なM&Aが展開され、市場の寡占化が進行したが、この背景となった市場動向を分析し、同時に同国の製薬産業に対する投資促進制度等を検証した。また、医療費削減のために採られたジェネリック医薬品処方に纏わる諸問題の存在も明らかにし、イギリスの行政面と産業面において我が国が参照すべき点や警戒すべき点等を考察した。","subitem_description_language":"ja","subitem_description_type":"Other"}]},"item_3_description_11":{"attribute_name":"抄録(英)","attribute_value_mlt":[{"subitem_description":"Abe Cabinet, announced long-term strategy of the 2025 \"Innovation 25\". And he toldto the center of the strategy to improve the innovation and productivity. On the basis ofthis opinion, he said it should be on the development of drugs and medical devices thecenter of the growth strategy.By the way, Cameron Cabinet of the United Kingdom, have achieved economic growthabove the peak of the economic crisis before. However, it is expected to stretch the widthof the real income is small, productivity has not been much improvement, the future economicgrowth of the UK to contract. And they have done a severe austerity also currently.Like Japan, in response to the aging of the population, the UK government, has continuedto reduce health care costs, this has been going on from the Thatcher regime.Under the environment of the market such as this, M & A of the leading pharmaceuticalcompanies in the UK is deployed. It also analyzes the market trends that became thisbackground, I have examined the investment promotion policy of pharmaceutical companiesby the government. And I discussed was adopted for medical cost-containment measures,on issues of generic drugs.","subitem_description_language":"en","subitem_description_type":"Other"}]},"item_3_description_15":{"attribute_name":"表示順","attribute_value_mlt":[{"subitem_description":"1","subitem_description_type":"Other"}]},"item_3_description_16":{"attribute_name":"アクセション番号","attribute_value_mlt":[{"subitem_description":"KJ00010104079","subitem_description_type":"Other"}]},"item_3_description_8":{"attribute_name":"記事種別(日)","attribute_value_mlt":[{"subitem_description":"論文","subitem_description_language":"ja","subitem_description_type":"Other"}]},"item_3_description_9":{"attribute_name":"記事種別(英)","attribute_value_mlt":[{"subitem_description":"Article","subitem_description_language":"en","subitem_description_type":"Other"}]},"item_3_publisher_22":{"attribute_name":"出版社","attribute_value_mlt":[{"subitem_publisher":"尚美学園大学総合政策学部","subitem_publisher_language":"ja"}]},"item_3_source_id_1":{"attribute_name":"雑誌書誌ID","attribute_value_mlt":[{"subitem_source_identifier":"AA11546318","subitem_source_identifier_type":"NCID"}]},"item_3_source_id_19":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"13463802","subitem_source_identifier_type":"PISSN"}]},"item_3_text_6":{"attribute_name":"著者所属(日)","attribute_value_mlt":[{"subitem_text_language":"ja","subitem_text_value":"尚美学園大学総合政策学部非常勤"}]},"item_3_text_7":{"attribute_name":"著者所属(英)","attribute_value_mlt":[{"subitem_text_language":"en","subitem_text_value":"Shobi University"}]},"item_3_title_3":{"attribute_name":"論文名よみ","attribute_value_mlt":[{"subitem_title":"エイコク キャメロン セイケンカ ノ イヤクヒン サンギョウ ト イリョウ セイド カイカク ニ カンスル イチコウサツ : サンギョウ ジュンカン ノ シテン カラ"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"楠本, 眞司","creatorNameLang":"ja"},{"creatorName":"クスモト, シンジ","creatorNameLang":"ja-Kana"},{"creatorName":"KUSUMOTO, Shinji","creatorNameLang":"en"}],"nameIdentifiers":[{}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2017-04-21"}],"displaytype":"detail","filename":"KJ00010104079.pdf","filesize":[{"value":"1.0 MB"}],"format":"application/pdf","licensetype":"license_11","mimetype":"application/pdf","url":{"label":"KJ00010104079.pdf","url":"https://shobi-u.repo.nii.ac.jp/record/157/files/KJ00010104079.pdf"},"version_id":"d9c683dd-eb07-4512-81a8-ccba088afa2d"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"NHS歳出抑制政策","subitem_subject_language":"ja","subitem_subject_scheme":"Other"},{"subitem_subject":"特許の崖","subitem_subject_language":"ja","subitem_subject_scheme":"Other"},{"subitem_subject":"ジェネリック医薬品の急速な成長","subitem_subject_language":"ja","subitem_subject_scheme":"Other"},{"subitem_subject":"イギリスのプライマリー・ヘルスケアサービス","subitem_subject_language":"ja","subitem_subject_scheme":"Other"},{"subitem_subject":"NHS expenditure control policies","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Cliff of patent","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Primary health care services in the UK","subitem_subject_language":"en","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"departmental bulletin paper","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"英国キャメロン政権下の医薬品産業と医療制度改革に関する一考察 : 産業循環の視点から","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"英国キャメロン政権下の医薬品産業と医療制度改革に関する一考察 : 産業循環の視点から","subitem_title_language":"ja"},{"subitem_title":"Study on health care reform and the pharmaceutical industry in the Cameron government in the UK : From the point of view of the industrial cycle","subitem_title_language":"en"}]},"item_type_id":"3","owner":"3","path":["32"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2017-04-21"},"publish_date":"2017-04-21","publish_status":"0","recid":"157","relation_version_is_last":true,"title":["英国キャメロン政権下の医薬品産業と医療制度改革に関する一考察 : 産業循環の視点から"],"weko_creator_id":"3","weko_shared_id":-1},"updated":"2024-04-26T07:25:27.062658+00:00"}